Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call
Rhea-AI Summary
Nutex Health (NASDAQ: NUTX) will file its Form 10-Q for the quarter ended March 31, 2026, and issue a press release with financial results on April 30, 2026 after market close.
The company will host an earnings conference call on May 1, 2026 at 9:30 a.m. CT; a recording and transcript will be posted under Investor Materials.
Positive
- None.
Negative
- None.
News Market Reaction – NUTX
In the Apr 23 session, NUTX gained 0.84%, reflecting a mild positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 25 | Earnings schedule | Neutral | +6.7% | Announced 2025 10-K filing date and related earnings call logistics. |
| Aug 08 | Earnings schedule | Neutral | -1.5% | Set Q2 2025 results release timing and follow-up conference call. |
| May 07 | Earnings schedule | Neutral | -11.6% | Outlined Q1 2025 results release date and investor conference call. |
| Mar 27 | Earnings reschedule | Neutral | -7.1% | Rescheduled 2024 year-end earnings release and call within filing window. |
| Mar 17 | Earnings schedule | Neutral | +5.0% | Announced Q4 and full-year 2024 reporting timeline and call details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings/conference scheduling headlines have led to mixed single-day moves, averaging about -1.7% across recent similar events.
Recent Nutex headlines show a pattern of routinely announcing earnings release dates and conference calls, including Q1, Q2, and year-end results across 2024–2025. These scheduling updates have produced a mix of positive and negative one-day moves, from about -11.62% to +6.73%, yielding an average move near -1.7%. Today’s Q1 2026 scheduling notice continues this cadence of regular financial communication without adding new fundamental metrics ahead of the upcoming Form 10-Q filing.
Key Terms
form 10-q regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Nutex Health will host its earnings conference call on Friday, May 1, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a business update.
Conference Call Details
Date: Friday, May 1, 2026
Time: 9:30 a.m. CT
Participant Listening: 1-877-407-9208 or 1-201-493-6784
Call me™: https://callme.viavid.com/viavid/?callme=true&passcode=13746493&h=true&info=company&r=true&B=6
Participants can use the guest dial-in numbers above and be answered by an operator or click the Call me™ link for instant telephone access to the event.
- The Call me™ link will be made active 15 minutes prior to scheduled start time.
Following the event, a transcript and recording of the call will be available on the Company's website under "Investor Materials."
About Nutex Health Inc.
Headquartered in
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 27 facilities in 12 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations. Through our Management Services Organization, we provide management, administrative and other support services to our affiliated hospitals and physician groups.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words or phrases "will," "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act, to remediate our material weaknesses in a timely manner, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2025, under the heading "Risk Factors" in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
View original content:https://www.prnewswire.com/news-releases/nutex-health-schedules-2026-first-quarter-financial-results-release-and-conference-call-302750754.html
SOURCE Nutex Health, Inc.